21 May 2009
Early postoperative complications of expanded criteria living kidney donors’ nephrectomies
R Kieszek, M Bieniasz, P Domagała, J Gozdowska, A Kwiatkowski, L Adadyński, J Trzebicki, M Durlik, L Pączek, A ChmuraAnn Transplant 2009; 14(1): 58-58 :: ID: 880411
Abstract
Background: Organs from living donors with expanded criteria (ECLD) are one of the ways to increase the number of transplantations. There is no comprehensive definition of this status. The aim of this study was to analyse early postoperative complications of living kidney donors' with expanded criteria versus optimal donors' postoperative complications.
Material/Methods: The records of 76 living donors were reviewed. Those
included age, BMI, hypertension, lipid disorders as the major risk factors (2
points each), gout, nephrolithiasis, nephrocysts, renal disorders in the family
diabetes, smoking history, HBC and HCV infections, venous thromboembolism, mental health disorders and vascular abnormalities as minor risk factors (1 point each). Patients were divided into two groups, optimal patients (0-5 points) and expanded criteria patients (6 points and more). There were 69 patients in the first group, 7 patients in the second group.
Results: There were three patients with diagnosed complications in the expanded criteria group (42.8%), and twenty two patients with diagnosed complication in the optimal group (OLD) (31.9%).
Conclusions: Nephrectomy in living kidney donors with expanded criteria is safe and there is no higher risk of early postoperative complications.
Keywords: Kidney Transplantation, Living Donors
In Press
Original article
Survival Analysis of Liver Transplants in Patients with Acute Liver Failure from Acetaminophen and Mushroom...Ann Transplant In Press; DOI: 10.12659/AOT.946485
Original article
Medication Adherence Among Pediatric Post-Heart Transplant Patients in a Tertiary Care HospitalAnn Transplant In Press; DOI: 10.12659/AOT.946905
Most Viewed Current Articles
03 Jan 2023 : Original article 6,394
Impact of Autologous Stem Cell Transplantation on Primary Central Nervous System Lymphoma in First-Line and...DOI :10.12659/AOT.938467
Ann Transplant 2023; 28:e938467
16 May 2023 : Original article 6,055
Breaking Antimicrobial Resistance: High-Dose Amoxicillin with Clavulanic Acid for Urinary Tract Infections ...DOI :10.12659/AOT.939258
Ann Transplant 2023; 28:e939258
15 Aug 2023 : Review article 5,992
Free-Circulating Nucleic Acids as Biomarkers in Patients After Solid Organ TransplantationDOI :10.12659/AOT.939750
Ann Transplant 2023; 28:e939750
17 Jan 2023 : Original article 5,173
Non-Cryopreserved Peripheral Blood Stem Cell Graft for Autologous Hematopoietic Stem Cell Transplantation i...DOI :10.12659/AOT.938595
Ann Transplant 2023; 28:e938595